No Data
J&J Prostate Cancer Therapy Outperforms in Real-world Study
Zacks Investment Ideas Feature Highlights: Coca-Cola, Pfizer and Altria
Eli Lilly and Co (LLY.US) explores new uses for "miracle weight-loss drug" Zepbound, aiming to reduce the incidence of diabetes and other high-risk populations.
eli lilly and co is exploring new uses for its weight loss drug Zepbound to reduce the incidence of diabetes in high-risk populations, even if they are not overweight.
Health Care Drops on Regulatory Fears - Health Care Roundup
Pfizer Options Spot-On: On October 1st, 60,652 Contracts Were Traded, With 2.78 Million Open Interest
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could Be Next
No Data
No Data
Deep Sea OP : The company will have more cash on hand![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
70523852 : Why sold so much shares?
70523852 : I guess my question is why would PFE want to sell so much shares of HLN. HLN still offers dividends. Since they sold them, wouldn’t that lower their future income? I can’t find any explanation on the purpose behind such a huge sell.
Deep Sea OP 70523852 : HLN got low dividend yield of less than 2%. Maybe PFE needs some cash to fund future acquisition of other companies.
70523852 Deep Sea OP : Got it.
Thank you!
View more comments...